Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization

Molecular and Cellular Biology

Volumn 27, Issue 12, 2007, Pages 4465-4474

  Yoshiko, Yuji ^a,b   Candeliere, G Antonio ^b   Maeda, Norihiko ^a   Aubin, Jane E ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; HYPOCALCIN; PHOSPHATE; PROTEIN PIT1; SODIUM PHOSPHATE COTRANSPORTER; UNCLASSIFIED DRUG; BETA-GLYCEROPHOSPHORIC ACID; GLYCEROL 2 PHOSPHATE; GLYCEROPHOSPHATE; GLYCOPROTEIN; PHOSPHORUS; SODIUM PHOSPHATE COTRANSPORTER 3; TRANSCRIPTION FACTOR PIT 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CALVARIA; CONTROLLED STUDY; EARLY RESPONSE GENE; GENE OVEREXPRESSION; NEWBORN; NONHUMAN; OSTEOBLAST; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL STRAIN 3T3; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; SKULL; WISTAR RAT;

RATTUS;

3T3 CELLS; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; FOSCARNET; GENE EXPRESSION REGULATION; GLYCEROPHOSPHATES; GLYCOPROTEINS; HUMANS; MICE; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOSARCOMA; PHOSPHORUS; RATS; RATS, WISTAR; SKULL; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; TRANSCRIPTION FACTOR PIT-1;

EID: 34250197188     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00104-07     Document Type: Article

References (44)

1. ADHR Consortium. 2000. Autosomal dominanl hypophosphatacmic rickets is associated with mutations in FGF23. Nat. Genet. 26:345-348.
2. Aubin, I. E., I. B. Lain, and G. S. Stein. 2006. Bone formation: maturation and functional activities of osteoblast lineage cells, p. 20-29. In M. J. Favus (ed.), Primer on the melabolic bone diseases and disorders of mineral metabolism, 6th ed. American Society for Bone and Mineral Research, Washington, DC.
3. Beck, G. R., Jr., and N. Knecht. 2003. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J. Biol. Chem. 278:41921-41929.
4. Beck, G. R., Jr. 2003. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J. Cell. Biochem. 90:234-243.
5. Beck, G. R., Jr., B. Zerler, and E. Moran. 2000. Phosphate is a specific signal for induction of osteopontin gene expression. Proc. Natl. Acad. Sci. USA 97:8352-8357.
6. Beck, L., A. C. Karaplis, N. Amizuka, A. S. Hewson, H. Ozawa, and H. S. Tenenhouse. 1998. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl. Acad. Sci. USA 95:5327-5377.
7. Bellows, C. G., J. N. Heersche, and J. E. Aubin. 1992. Inorganic phosphate added exogenously or released from β-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone Miner. 17:15-29.
8. Bellows, C. G., J. E. Aubin, J. N. M. Heersche, and M. E. Antosz. 1986. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif. Tissue Int. 38:143-154.
9. Berndt, T., T. A. Craig, A. E. Bowe, J. Vassiliadis, D. Reczek, R. Finnegan, S. M. Jan De Beur, S. C. Schiavi, and R. Kumar. 2003. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J. Clin. Investig. 112:785-794.
10. Chang, A. C., J. Cha, F. Roentgen, and R. R. Reddel. 2005. The murine stanniocalcin 1 gene is not essential for growth and development. Mol. Cell. Biol. 25:10604-10610.
11. Chang, A. C., J. Janosi, M. Hulsbeek, D. de Jong, K. J. Jeffrey, J. R. Noble, and R. R. Reddel. 1995. A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol. Cell. Endocrinol. 112:241-247.
12. De Beur, S. M., R. B. Finnegan, J. Vassiliadis, B. Cook, D. Barberio, S. Estes, P. Manavalan, J. Petroziello, S. L. Madden, J. Y. Cho, R. Kumar, M. A. Levine, and S. C. Schiavi. 2002. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J. Bone Miner. Res. 17:1102-1110.
13. Ecarot, B., F. H. Glorieux, M. Dcsbarats, R. Travers, and L. L. Labelle. 1992. Defective bone formation by Hyp mouse bone cells transplanted into normal mice: evidence in favor of an intrinsic osteoblast defect. J. Bone Miner. Res. 7:215-220.
14. Edwards, D. R., and L. C. Mahadevan. 1992. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence lor labile repressors. EMBO J. 11:2415-2424.
15. Feng, J. Q., L. M. Ward, S. Liu, Y. Lu, Y. Xie, B. Yuan, X. Yu, F. Rauch, S. I. Davis, S. Zhang, H. Rios, M. K. Drezner, L. D. Quarles, L. F. Bonewald, and K. E. White. 2006. Loss of DMPI causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 38:1310-1315.
16. Filvaroff, E. H., S. Guillet, C. Zlot, M. Bao, G. Ingle, H. Steinmetz, J. Hoeffel, S. Bunting, J. Ross, R. A. Carano, L. Powell-Braxton, G. F. Wagner, R. Eckert, M. E. Gerritsen, and D. M. French. 2002. Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology 143:3681-3690.
17. Hisano, S., H. Haga, Z. Li, S. Tatsumi, K. I. Miyamoto, E. Takeda, and Y. Fukui. 1997. Immunohistochemical and RT-PCR detection of Na+-dependent inorganic phosphate cotransporter (NaPi-2) in rat brain. Brain Res. 772:149-155.
18. HYP Consortium. 1995. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat. Genet. 11:130-136.
19. Ishihashi, K., K. Miyamoto, Y. Taketani, K. Morita, E. Takeda, S. Sasaki, and M. Imai. 1998. Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem. Biophys. Res. Commun. 250:252-258.
20. Karsenty, G., and E. F. Wagner. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2:389-406.
21. Kavanaugh, M. P., D. G. Miller, W. Zhang, W. Law, S. L. Kozak, D. Rabat, and A. D. Miller. 1994. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 91:7071-7075.
22. Kimmel, C. A., and C. Trammell. 1981. A rapid procedure for routine double staining cartilage and bone in fetal and adult animals. Stain Technol. 56:271-273.
23. Larsson, T., R. Marsell, E. Schipani, C. Ohlsson, O. Ljunggren, H. S. Tenenhnuse, H. Juppner, and K. B. Jonsson. 2004. Transgenic mice expressing fibroblast growth factor 23 under the control of the α1 (1) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145:3087-3094.
24. Li, X., H. Y. Yang, and C. M. Giachelli. 2006. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ. Res. 98:905-912.
25. Meleti, Z., I. M. Shapiro, and C. S. Adams. 2000. Inorganic phosphate induces apoptosis of osteoblast-like cells in culture. Bone 27:359-366.
26. Mundy, G., R. Garrett, S. Harris, S. J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez. 1999. Stimulation of bone formation in vitro and in rodenls by statins. Science 286:1946-1949.
27. Paciga, M., C. R. McCudden, C. Londos, G. E. DiMattia, and G. F. Wagner. 2003. Targeting big stanniocalcin and its receptor to lipid storage droplets of ovarian steroidogenic cells. J. Biol. Chem. 278:49549-49554.
28. Palmer, G., J. Guicheux, J. P. Bonjour, and J. Caverzasio. 2000. Transforming growth factor-β stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology 141:2236-2243.
29. Palmer, G., J. P. Bonjour, and J. Caverzasio. 1997. Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology 138:5202-5209.
30. Pizurki, L., R. Rizzoli, J. Caverzasio, and J. P. Bonjour. 1991. Stimulation by parathyroid hormone-related protein and transforming growth factor-α of phosphate transport in osteoblast-like cells. J. Bone Miner. Res. 6:1235-1241.
31. Quarles, L. D. 2003. Evidence for a bone-kidney axis regulating phosphate homeostasis. J. Clin. Investig. 112:642-646.
32. Rowe, P. S. N., P. de Zoysa, R. Dong, H. Wang, K. White, M. J. Econs, and C. L. Oudet. 2000. MEPE, a new gene expressed in bone-marrow and tumors causing osteomalacia. Genomics 67:54-68.
33. Sato, T., T. Maekawa, S. Watanabe, K. Tsuji, and T. Nakahata. 2000. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. J. Clin. Investig. 16:263-270.
34. Shimada, T., M. Kakitani, Y. Yamazaki, H. Hasegawa, Y. Takeuchi, T. Fujita, S. Fukumoto, K. Tomizuka, and T. Yamashita. 2004. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Investig. 113:561-568.
35. Sitara, D., M. S. Razzaque, M. Hesse, S. Yoganathan, T. Taguchi, R. G. Erben, H. Juppner, and B. Lanske. 2004. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis and reverses ypophosphatemia in Phex-deficent mice. Matrix Biol. 23:421-432.
36. Suzuki, A., C. Ghayor, J. Guicheux, D. Magne, S. Quillard, A. Kakita, Y. Ono, Y. Miura, Y. Oiso, M. Itoh, and J. Caverzasio. 2006. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J. Bone Miner. Res. 21:674-683.
37. Suzuki, A., G. Palmer, J. P. Bonjour, and J. Caverzasio. 2000. Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells. J. Bone Miner. Res. 15:95-102.
38. Swenson, C. L., S. E. Weisbrode, L. A. Nagode, K. A. Hayse, C. L. Steinmeyer, and L. E. Mathes. 1991. Age-related differences in phosphono-formate-induced bone toxicity in cats. Calcif. Tissue Int. 48:353-361.
39. +-phosphate cotransport in mouse distal convoluted tubule cells: evidence for Glvr-1 and Ram-1 gene expression. J. Bone Miner. Res. 13:590-597.
40. Varghese, R., A. D. Gagliardi, P. E. Bialek, S. P. Yee, G. F. Wagner, and G. E. Dimattia. 2002. Overexpression of human stanniocalin affects growth and reproduction in transgenic mice. Endocrinology 143:868-876.
41. Wennberg, C., L. Hessle, P. Lundberg, S. Mauro, S. Narisawa, U. H. Lerner, and J. L. Millan. 2000. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J. Bone Miner. Res. 15:1879-1888.
42. Yoshiko, Y., N. Maeda, and J. E. Aubin. 2003. Stanniocalcin 1 stimulates osteoblast differentiation in rat calvaria cell cultures. Endocrinology 144:4134-4143.
43. Zhang, K., P. J. Lindsberg, T. Tatlisumak, M. Kaste, H. S. Olsen, and L. C. Andersson. 2000. Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc. Natl. Acad. Sci. USA 97:3637-3642.
44. Zhen, X., J. P. Bonjour, and J. Caverzasio. 1997. Platelet-derived growth factor stimulates sodium-dependent Pi transport in osteoblastic cells via phospholipase Cγ and phosphatidylinositol 3′-kinase. J. Bone Miner. Res. 12:36-44.